Volume 54, Issue 3 pp. 427-431
Research Article

Prognosis of severe carpal tunnel syndrome with absent compound muscle action potential

Hisao Kamiya MD

Hisao Kamiya MD

Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan

Search for more papers by this author
Michio Kimura MD

Michio Kimura MD

Department of Orthopaedic Surgery, Teikyo University School of Medicine, Tokyo, Japan

Search for more papers by this author
Satoshi Hoshino DMC

Satoshi Hoshino DMC

Central Laboratory, Teikyo University School of Medicine, Tokyo, Japan

Search for more papers by this author
Masahito Kobayashi PhD

Masahito Kobayashi PhD

Faculty of Economics, Yokohama National University, Yokohama, Japan

Search for more papers by this author
Masahiro Sonoo MD

Corresponding Author

Masahiro Sonoo MD

Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan

Correspondence to: M. Sonoo; e-mail: [email protected]Search for more papers by this author
First published: 10 December 2015
Citations: 11

ABSTRACT

Introduction

Opponensplasty is a surgical option for patients with severe carpal tunnel syndrome (CTS). We investigated prognostic factors of patients who lack a preoperative compound muscle action potential (CMAP) of the abductor pollicis brevis (APB) muscle to determine the necessity for single-stage opponensplasty.

Methods

We retrospectively enrolled 22 hands of 22 CTS patients. Prognostic factors considered were age, diabetes mellitus, the median sensory nerve action potential, distal motor latency of the second lumbrical (2L) CMAP (2L-DML), and its amplitude (2L-Amp). Postoperative APB-CMAP amplitude (post APB-Amp) at 12 months was used as the outcome measure.

Results

Only 2L-DML showed a significant correlation with post APB-Amp (r = -0.56). The contribution of 2L-Amp was not significant, although 3 hands with absent 2L-CMAP had a poor electrophysiological recovery.

Conclusions

Prolonged 2L-DML and absent 2L-CMAP seem to be poor prognostic factors. Concurrent opponensplasty may not be necessary in patients with 2L-DML of 8 ms or less. Muscle Nerve 54: 427–431, 2016

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me